Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Therma Bright ( (TSE:THRM) ) has shared an update.
Therma Bright Inc. has secured a purchase order for 1,750 Venowave VW5 units from DME Authority, a national distributor based in Nashville, Tennessee. This agreement marks a significant step forward in their partnership, positioning DME as a premier distributor partner for Therma Bright. The purchase order, valued at over $1.4 million USD, is poised to enhance Therma Bright’s market presence in the U.S., with the Venowave VW5 offering unique benefits as a Medicare-approved mobile mechanical compression system. The global compression therapy market is expected to grow significantly, providing a favorable environment for Therma Bright’s innovative products.
More about Therma Bright
Therma Bright Inc. is a developer and investment partner specializing in advanced diagnostic and medical device technologies. The company focuses on creating innovative solutions in the healthcare industry, particularly in the field of vascular compression therapy.
YTD Price Performance: 8.00%
Average Trading Volume: 255,262
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $12.51M
See more insights into THRM stock on TipRanks’ Stock Analysis page.
